Imipenem-resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1094-1098

  Troillet, Nicolas ^a,b   Samore, Matthew H ^a   Carmeli, Yehuda ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Ctrl Inst of the Valais Hospitals   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; IMIPENEM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030729148     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516092     Document Type: Conference Paper

References (18)

1. Hospital Infection Program, Center for Disease Control and Prevention. NNIS semianual report, May 1996. Internet 1996 (http://www.cdc.gov/ ncidod/diseases/hip/nnis/nnis0596.htm).
2. Sanders CC, Sanders WE Jr. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824-39.
3. Gaynes RP, Culver DH, the National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10-4.
4. Quinn JP. Imipenem resistance among gram-negative bacilli [editorial]. Eur J Clin Microbiol Infect Dis 1994;13:203-4.
5. Livermore DM. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992;36:2046-8.
6. Watanabe M, lyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:147-51.
7. Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metalloβ-lactamase-producing Pseudomonas aeruginosa resistant to broadspectrum β-lactams, including carbapenems. Antimicrob Agents Chemother 1996;40:349-53.
8. Milatovic D, Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol 1987;6:234-44.
9. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38:547-57.
10. Iten A, Cometta A, Moreillon Ph, Eggimann Ph, Siegrist H, Francioli P. Addition of netilmicin to imipenem does not prevent the emergence of imipenem-resistance during treatment of severe infections [abstract no, C112]. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1996:54.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
12. Quinn JP, Studemeister AE, DiVincenzo CA, Lemer SA. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev Infect Dis 1988;10:892-8.
13. Morrison AJ Jr, Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984;6(suppl 3):S627-42.
14. Schimpf SC, Moody M, Young VM. Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients. In: Hobby GL, ed. Antimicrobial agents and chemotherapy - 1970. Washington, DC: American Society for Microbiology, 1971:240-4.
15. Quinn JP, Dudek EJ, DiVincenzo CA, Lucks DA, Lemer SA. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 1986;154:289-94.
16. Satake S, Yoneyama H, Nakae T. Role of Omp D2 and chromosomal βlactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1991;28:199-207.
17. Neu HC. Resistance of Pseudomonas aeruginosa to imipenem [editorial]. Infect Control Hosp Epidemiol 1992;13:7-9.
18. Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V. Role of mutations in DNA gyrase gene in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem. Antimicrob Agents Chemother 1995;39:2248-52.